SEARCH

SEARCH BY CITATION

References

  • 1
    Van der Waaij D. Colonisation resistance of the digestive tract: clinical consequences and implications. J Antimicrob Chemother 1982; 70: 26379.
  • 2
    Bullen CL, Willis AT. Resistance of the breast-fed infant to gastro-enteritis. Br Med J 1971; 3: 33843.
  • 3
    Wang X, Gibson GR. Effects of in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. J Appl Bacteriol 1993; 75: 37380.
  • 4
    Gibson GR, Wang X. Regulatory effects of bifidobacteria on the growth of colonic bacteria. J Appl Bacteriol 1994; 77: 41220.
  • 5
    Marteau P, Pochart P, Flourie B, et al. Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in humans. Am J Clin Nutr 1990; 52: 6858.
  • 6
    Colombel JF, Cortot A, Neut C, Romond C. Yoghurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effects. Lancet 1987; ii: 43.
  • 7
    Reddy BS, Rivenson A. Inhibitory effect of Bifidobacterium longum on the colon, mammary and liver carcinogenesis induced by 2 amino-3-metylimidazo[4, 5-f] quinoline, a food mutagen. Cancer 1993; 53: 39148.
  • 8
    Koo M, Rao AV. Long-term effect of bifidobacteria and Neosugar on precursor lesions of colonic cancer in CF1 mice. Nutr Rev 1991; 51: 13746.
  • 9
    Wells CL, Maddaus LA, Jechorek RP, Simmons RL. Role of intestinal anaerobic bacteria in colonisation resistance. Eur J Clin Microbiol Infect Dis 1988; 7: 10713.
  • 10
    Yamazaki S, Kamimura H, Momose H, Kawashima T, Ueda K. Protective effect of Bifidobacterium monoassociation against lethal activity of E. coli. Bifidobacteria Microflora 1982; 1: 5560.
  • 11
    Gorbach SL, Chang TW, Goldin B. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 1987; 2: 1519.
  • 12
    Chapoy P. Traitement des diarrhées aiguës infantiles: essai contrôlé de Saccharomyces boulardii. Ann Pédiatr 1985; 32: 5613.
  • 13
    Kimmey MB, Elmer GW, Surawicz CM, McFarland LV. Prevention of further recurrences of Clostridium difficile colitis with Saccharomyces boulardii. Dig Dis Sci 1990; 35: 897901.
  • 14
    Saint-Marc T, Rossello-Prats L, Touraine JL. Saccharomyces boulardii dans le traitement des diarrhées du SIDA. Ann Med Interne 1991; 142: 645.
  • 15
    Surawicz CM, Elmer G, Speelman P, McFarland LV, Chinn J, Belle G. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989; 96: 9818.
  • 16
    Lewis SJ, Freedman AR. The use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease. Aliment Pharmacol Ther 1998; 12: 80722.
  • 17
    Blehaut H, Massot J, Elmer GW, Levey RH. Disposition kinetics of Saccharomyces boulardii in man and rat. Biopharm Drug Dispos 1989; 10: 35364.
  • 18
    Molis C, Flourié B, Ouarne F, et al. Digestion, excretion, and energy value of fructooligosaccharides in healthy humans. Am J Clin Nutr 1996; 64: 3248.
  • 19
    Gibson GR, Beatty ER, Wang X, Cummings JH. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995; 108: 97582.
  • 20
    Wolf BW, Meulbroek JA, Jarvis KP, Wheeler KP, Garleb KA. Dietary supplementation with fructooligosaccharides increase survival time in a hamster model of Clostridium difficile-colitis. Biosci Microflora 1997; 16: 5964.
  • 21
    Gerding DN, Olson MM, Peterson LR, et al. Clostridium difficile-associated diarrhea and colitis in adults. Arch Intern Med 1986; 146: 95100.
  • 22
    Beerens H. An elective and selective isolation medium for Bifidobacterium spp. Lett Appl Microbiol 1990; 11: 1557.
  • 23
    Brazier JS. The diagnosis of Clostridium difficile associated disease. J Antimicrob Chemother 1998; 41 (Suppl. C): 2940.
  • 24
    Bovee-Oudenhoven IMJ, Bruggencate JJM, Lettink-Wissink MLG, Van der Meer R. Dietary fructo-oligosaccharides and lactulose inhibit intestinal colonisation but stimulate translocation of Salmonella in rats. Gut 2003; 52: 15728.
  • 25
    Ten Bruggencate SJ, Bovee-Oudenhoven IM, Lettink-Wissink ML, Katan MB, Van Der Meer R. Dietary fructo-oligosaccharides and inulin decrease resistance of rats to Salmonella: protective role of calcium. Gut 2004; 53: 5305.
  • 26
    Orrhage K, Sjostedt S, Nord CE. Effects of supplements with lactic acid bacteria and oligofructose on the intestinal microflora during administration of cefpodoxime proxetil. J Antimicrob Chemother 2000; 46: 60312.
  • 27
    Cummings JH, Christie C, Cole TJ. A study of fructo-oligosaccharides in the prevention of travellers diarrhoea. Aliment Pharmacol Ther 2001; 15: 113945.
  • 28
    Rao SS, Edwards CA, Austen C. Impaired colonic fermentation of carbohydrate after ampicillin. Gastroenterology 1998; 94: 92832.
  • 29
    Cunningham R, Dale B, Undy B, Gaunt N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect 2003; 54: 2435.